Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon consent order

This article was originally published in The Rose Sheet

Executive Summary

Federal Trade Commission publishes consent order in the Dec. 29 Federal Register as final step of settlement of alleged violations of unfair practices and unfair methods of competition laws by Revlon's Ultima II ProCollagen Anti-Cellulite Body Complex and PhotoAging Shield products. Under the agreement, Revlon is required to have scientific evidence to support future claims for the effectiveness of cellulite treatments or sunscreen products and to state the SPF value in any ad making sun protection claims. Violation of the order may result in a civil penalty of up to $10,000. FTC gave final approval to the consent agreement with Revlon in November ("The Rose Sheet" Nov. 29, In Brief). FTC filed the complaint in September 1989 ("The Rose Sheet" Sept. 18, 1989, p. 3)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000024

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel